Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion

Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate

(2009) T. Terada et al.   ACTA NEUROLOGICA SCANDINAVICA

Development of oligomeric prion-protein aggregates in a mouse model of prion disease

(2009) Kensuke Sasaki et al.   JOURNAL OF PATHOLOGY

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

(2009) John Collinge et al.   LANCET NEUROLOGY

Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns

(2009) Haruhiko Minaki et al.   NEUROPATHOLOGY

Continuous intraventricular infusion of pentosan polysulfate: Clinical trial against prion diseases

(2009) Yoshio Tsuboi et al.   NEUROPATHOLOGY

Amyloidogenic properties of the prion protein fragment PrP(185–208): Comparison with Alzheimer’s peptide Aβ(1–28), influence of heparin and cell toxicity

(2008) Marta Cortijo-Arellano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK

(2008) I. Bone et al.   EUROPEAN JOURNAL OF NEUROLOGY